|
|
Genionics is a privately owned company dedicated to ion channel research. We offer a range of products that facilitate drug discovery, diagnostics and clinical management. Our expertise is in the development of next generation ion channel cell lines that are ready-to-use in drug screening projects.
Our proprietary ChanClone™ technology enables us to design ion channel cell lines extremely rapidly. We are building up a comprehensive ion channel cell collection that includes polymorphic and mutated ion channel variants.
Our goal is to bridge the gap between genetic diversity and in vitro screening of ion channels. We promote ion channel allele screening in order to accelerate the advancement of personalized medicine in the area of ion channel diseases.
Genionics is located at the Biotech Center of Zurich in Switzerland.
|
|
|
31 March 2009
Swiss Equity Biotech Day
CEO Markus Aebi presented Genionics at the Swiss Biotech Day [click]
26 March 2009
Podium Discussion
Genionics participates at the Avireal Business Talk! Stephan Klapproth
moderated a podium talk entitled ¨Growth through Innovation¨ at the this
year`s Avireal Spring Apéro. Guests were Prof. Dr. Lothar Späth, Prof. Dr.
Markus Gross and Dr. Urs Thomet.
5-6 February 2009
Ion Channels as Therapeutic Targets 2009
Genionics presented a poster called "Development of a medium-throughput
electrophysiology assay to investigate state-dependency of sodium channel
blockers using QPatch at Novartis, Horsham UK. [click]
13-14 November 2008
Channelopathy Database
Together with the Channelopathy Foundation Genionics organized a roundtable
meeting with opinion leaders to initiate the Channelopathy Database Project, Zurich,
Switzerland.
|
|
|
 |
Ion Channel collection
Our ion channel cell products were developed using our specialized scientific expertise. We provide a broad collection of high-end ion channel reagents ready-to-use in drug screening projects. |
|